The latest from Redeye about Scandinavian Life Science and Technology companies

Theme: Online Gambling

Get in the game and place your bets!

Find out more

Theme: Cybersecurity

Cyberattacks on the rise - Can we win the battle?

Find out more

Theme: Gaming

Super Investment Gaming Guide - In depths on the bits and pixels of the Gaming industry. GLHF

Find out more

Theme: Fight Cancer

There is a war on cancer and now, for the first time ever we see an opportunity for winning.

Find out more

Smart Eye

Q1'18: Entering Japan

Research Note 2018-04-25
SEYE
icon-company Smart Eye

Q1'18: Entering Japan

Research Note 2018-04-25 Viktor Westman

Smart Eye today, Wednesday, reported net sales and an operating loss of SEK 10m and -14m respectively. Our expectations were SEK 9m and SEK -20m

Continue reading

Event - InDex Pharmaceuticals' Capital Markets Day

Live Wednesday 9:15 AM

Video 2018-04-13
INDEX
icon-company InDex Pharmaceuticals

Live Wednesday 9:15 AM

Video 2018-04-12

Welcome to follow InDex Pharmaceuticals' live streamed Capital Markets Day here at Redeye.

Continue reading

Senzime

Tecknar nya distributionsavtal

Research Note 2018-04-25
SEZI
icon-company Senzime

Tecknar nya distributionsavtal

Research Note 2018-04-25 Andreas Kvist

I denna kommentar går vi igenom dagens nyhet där Senzime tecknade avtal med tre distributörer som täcker sex länder för TetraGraph.

Continue reading

SyntheticMR

Bra start på 2018

Research Note 2018-04-25
SYNT
icon-company SyntheticMR

Bra start på 2018

Research Note 2018-04-24 Andreas Kvist

I denna kommentar går vi igenom SyntheticMRs Q1-rapport som kom in något bättre än vi räknat med och bekräftar att caset är intakt.

Continue reading

Hansa Medical

Sammanfattning av Q1

Research Note 2018-04-25
HMED
icon-company Hansa Medical

Sammanfattning av Q1

Research Note 2018-04-25 Mathias Spinnars

Hansa Medicals första kvartal präglades av fullrekryterade fas II-studier inom njurtransplantation med interimsresultat från sju av 18 Highdes-patienter, samt en ny vd i Søren Tulstrup.

Continue reading

Enea

Q1'18: Bättre försäljning inom Openwave än väntat

Research Note 2018-04-25
ENEA
icon-company Enea

Q1'18: Bättre försäljning inom Openwave än väntat

Research Note 2018-04-25 Viktor Westman

Enea rapporterar i dag, onsdag, intäkter om 170 MSEK och EBIT på 27 MSEK (35 MSEK exklusive engångsposter) att jämföra med våra förväntningar på 161 och 32 MSEK.

Continue reading

Verisec

The key to growth

Research Update 2018-04-24
VERI
icon-company Verisec

The key to growth

Research Update 2018-04-24 Tomas Otterbeck

Verisec has a goal of reaching SEK 200 million in revenue by 2020. This is an aggressive target considering sales amounted to SEK 64 million in 2017. The majority of the growth is estimated to come from Freja eID. We have changed our fair value range in Verisec.

Continue reading

Events

26

Apr

Quarterly report presentation and Q&A - Bredband2

03

May

Investor After Work Malmö - 3 maj

03

May

Redeye Investor After Work Öresund

Announcements

Redeye Corporate Finance söker projektledare med intresse för gaming och betting

Redeye bistår Annexin Pharmaceuticals i fullt garanterad företrädesemission

Redeye bistår Teqnion i övertecknad private placement

You need to be a Redeye member to access this content

Become a member to:

By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions